Contraceptive prevalence, any modern method in Serbia
Serbia: Contraceptive prevalence, any modern method was 21.3% in 2019. ▼ Falling
Contraceptive prevalence, any modern method in Serbia, 2000–2019
Source: Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division. Measured in % of married women ages 15-49.
Analysis
In 2019, contraceptive prevalence, any modern method in Serbia stood at 21.3%.
Compared with earlier readings it is down 4.0% over ten years.
Over the whole period, contraceptive prevalence, any modern method in Serbia peaked at 33.0% in 2000 and was at its lowest, 18.4%, in 2014.
That places Serbia 95th out of 113 countries with data for 2019, putting it in the bottom quarter.
Contraceptive prevalence, any modern method in Serbia, year by year
| Year | % of married women ages 15-49 | Change |
|---|---|---|
| 2000 | 33.0% | — |
| 2006 | 19.0% | -42.5% |
| 2010 | 22.2% | +17.2% |
| 2014 | 18.4% | -17.1% |
| 2019 | 21.3% | +15.8% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 26.0% | 19.0% | 33.0% | 2 |
| 2010s | 20.7% | 18.4% | 22.2% | 3 |
Countries ranked near Serbia
- 92 Timor-Leste 24.1% compare
- 93 Burundi 22.9% compare
- 94 Togo 21.4% compare
- 96 Sierra Leone 20.9% compare
- 97 Guinea-Bissau 20.2% compare
- 98 Afghanistan 19.8% compare
More health data for Serbia
- Un projection of annual infant deaths, annual growth rate -5.26 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.3584 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,502 deaths per 1,000 people (2090)
- Number of infants who die before age 1 18 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.67 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.022 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.67 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is contraceptive prevalence, any modern method in Serbia?
- Contraceptive prevalence, any modern method in Serbia was 21.3% in 2019, according to Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division.
- What is the highest contraceptive prevalence, any modern method recorded in Serbia?
- The highest recorded value was 33.0% in 2000.
- What is the lowest contraceptive prevalence, any modern method recorded in Serbia?
- The lowest recorded value was 18.4% in 2014.
- How does Serbia rank for contraceptive prevalence, any modern method?
- Serbia ranks 95th out of 113 countries with data for 2019.
- Is contraceptive prevalence, any modern method rising or falling in Serbia?
- Over the last ten years it is down 4.0%. The long-run trend across the full record is falling.
- Where does this Serbia data come from?
- The figures come from Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division, published as part of Contraceptive prevalence, any modern method (% of married women ages 15-49). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Contraceptive prevalence, any modern method is the percentage of married women ages 15-49 who are practicing, or whose sexual partners are practicing, at least one modern method of contraception. Modern methods of contraception include female and male sterilization, oral hormonal pills, the intra-uterine device (IUD), the male condom, injectables, the implant (including Norplant), vaginal barrier methods, the female condom and emergency contraception.